Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sayumi Suzuki"'
Autor:
Yuichiro Maekawa, Kenichiro Suwa, Keitaro Akita, Sanshiro Togo, Yuki Sugiura, Sayumi Suzuki, Kazuto Ohno, Shin-ichi Shibata, Michio Kimura
Publikováno v:
Open Heart, Vol 10, Iss 2 (2023)
Objectives In hypertrophic cardiomyopathy (HCM), specific ECG abnormalities are observed. Therefore, ECG is a valuable screening tool. Although several studies have reported on estimating the risk of developing fatal arrhythmias from ECG findings, th
Externí odkaz:
https://doaj.org/article/9b76bebfcb6f4e9db225a186817e2a46
Autor:
Hiromitsu Kataoka, Sayumi Suzuki, Yuichi Suzuki, Ryota Sato, Makoto Sano, Satoshi Mogi, Atsushi Sakamoto, Kenichiro Suwa, Yoshihisa Naruse, Hayato Ohtani, Masao Saotome, Mikihiro Shimizu, Keiichi Odagiri, Yuichiro Maekawa
Publikováno v:
Medicines, Vol 10, Iss 12, p 62 (2023)
Background: Malnutrition in cardiovascular disease is associated with poor prognosis, especially in patients with heart failure and acute coronary syndrome (ACS). High bleeding risk is also linked to coronary artery disease prognosis, including ACS.
Externí odkaz:
https://doaj.org/article/c61659e6f70e43598ad1812420b2e094
Autor:
Keitaro Akita, Shigetaka Kageyama, Sayumi Suzuki, Kazuto Ohno, Masamitsu Kamakura, Ryuzo Nawada, Chiei Takanaka, Yasushi Wakabayashi, Takahiro Kanda, Kei Tawarahara, Masahiro Mutoh, Masaki Matsunaga, Satoru Suwa, Yasuyo Takeuchi, Hiroki Sakamoto, Hideki Saito, Kazusa Hayashi, Nobuyuki Wakahara, Kyoko Unno, Takenori Ikoma
Publikováno v:
Heart; 7/15/2024, Vol. 110 Issue 14, p954-962, 9p
Autor:
Sanshiro Togo, Yuki Sugiura, Sayumi Suzuki, Kazuto Ohno, Keitaro Akita, Kenichiro Suwa, Shin-ichi Shibata, Michio Kimura, Yuichiro Maekawa
Publikováno v:
Open Heart (2053-3624); Jul2023, Vol. 10 Issue 2, p1-8, 8p
Autor:
Katsunori Yamaura, Tomoya Uehara, Yuki Nomura, Keisuke Gushimiyagi, Sana Siddig, Miaki Uzu, Yuko Sekine, Koichi Ueno, Yasushi Arano, Hiromi Sato, Tatsuro Kashiba, Sayumi Suzuki
Publikováno v:
European Journal of Pharmacology. 746:258-266
Intrinsic drug resistance occurs in many renal carcinomas and is associated with increased expression of multidrug resistant proteins, which inhibits intracellular drug accumulation. Multidrug resistant protein 1, also known as P-glycoprotein, is a m
Autor:
Yasutaka Senpuku, Takemichi Okada, Hitoshi Yamazaki, Karin Takeda, Sayumi Suzuki, Hiroaki Yokomori
Publikováno v:
Journal of Gastrointestinal & Digestive System. 6
A 73-year-old man was admitted to our hospital with fever of unknown origin (FUO). Laboratory findings showed high levels of C-reactive protein (25.99 mg/dL) and interleukin-6 (IL-6) (14.7 pg/mL). Computed tomography revealed right lateral pleural ef
Autor:
Tomohiro Yano, Sana Siddig, Yuki Nomura, Guligena Tuerdi, Miaki Uzu, Hiromi Sato, Hiroko Okuzawa, Sayumi Suzuki, Koichi Ueno, Rina Suzuki, Yuko Sekine
Publikováno v:
Cancer Research. 73:1043-1043
Sunitinib (SU) is a multi-targeted receptor tyrosine kinase inhibitor (TKI). It is more effective for renal cell carcinoma (RCC) treatment than conventional immunotherapy, but it causes the resistance and severe side effects in some cases. As a combi
Autor:
Yasushi Arano, Hiromi Sato, Yuko Sekine, Yuki Nomura, Sana Siddig, Koichi Ueno, Tomoya Uehara, Miaki Uzu, Rina Suzuki, Sayumi Suzuki
Publikováno v:
Cancer Research. 73:983-983
Sunitinib is a multi-targeted receptor tyrosine kinase inhibitor (TKI) and currently approved for use in advanced renal cell carcinoma (RCC). It is really attractive drug for patients who cannot have surgical treatment. However, it is reported that T